These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 9314633

  • 1. Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry.
    Vandewalle CL, Falorni A, Lernmark A, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK.
    Diabetes Care; 1997 Oct; 20(10):1547-52. PubMed ID: 9314633
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.
    Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.
    Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724
    [Abstract] [Full Text] [Related]

  • 4. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry.
    van der Auwera B, Schuit F, Lyaruu I, Falorni A, Svanholm S, Vandewalle CL, Gorus FK.
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2567-73. PubMed ID: 7673396
    [Abstract] [Full Text] [Related]

  • 5. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. The Belgian Diabetes Registry.
    Van der Auwera BJ, Vandewalle CL, Schuit FC, Winnock F, De Leeuw IH, Van Imschoot S, Lamberigts G, Gorus FK.
    Clin Exp Immunol; 1997 Oct; 110(1):98-103. PubMed ID: 9353155
    [Abstract] [Full Text] [Related]

  • 6. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*0301-DQB1*0302 haplotype at clinical type 1 (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. The Belgian Diabetes Registry.
    Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK.
    Diabetologia; 1993 Nov; 36(11):1155-62. PubMed ID: 8270130
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
    Wang JP, Zhang C, Lin J, Yuan Y, Zhou HF, Huang G, Zhou M, Zhou ZG.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 11; 87(34):2380-4. PubMed ID: 18036312
    [Abstract] [Full Text] [Related]

  • 8. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives.
    Wang JP, Zhou ZG, Lin J, Huang G, Zhang C, Yang L, Yuan Y, Zhou HF, Zhou M, Hou C, Zhou WD, Peng H, Hagopian WA.
    Tissue Antigens; 2007 Nov 11; 70(5):369-75. PubMed ID: 17919266
    [Abstract] [Full Text] [Related]

  • 9. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E, Savola K, Kulmala P, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, Ilonen J, Akerblom HK, Knip M.
    Clin Exp Immunol; 1999 Apr 11; 116(1):78-83. PubMed ID: 10209508
    [Abstract] [Full Text] [Related]

  • 10. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R, Vähäsalo P, Tuomilehto-Wolf E, Reijonen H, Kulmala P, Ilonen J, Akerblom HK, Knip M.
    Diabetes; 1995 Sep 11; 44(9):1021-8. PubMed ID: 7657023
    [Abstract] [Full Text] [Related]

  • 11. Population analysis of protection by HLA-DR and DQ genes from insulin-dependent diabetes mellitus in Swedish children with insulin-dependent diabetes and controls.
    Kockum I, Sanjeevi CB, Eastman S, Landin-Olsson M, Dahlquist G, Lernmark A.
    Eur J Immunogenet; 1995 Dec 11; 22(6):443-65. PubMed ID: 8597561
    [Abstract] [Full Text] [Related]

  • 12. The influence of age at onset and gender on the HLA-DQA1, DQB1 association in Chinese children with insulin dependent diabetes mellitus.
    Chen BH, Chiang CH, Lin SR, Chao MG, Tsai ST.
    Hum Immunol; 1999 Nov 11; 60(11):1131-7. PubMed ID: 10600012
    [Abstract] [Full Text] [Related]

  • 13. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.
    J Clin Endocrinol Metab; 1996 Apr 11; 81(4):1488-94. PubMed ID: 8636356
    [Abstract] [Full Text] [Related]

  • 14. Relative and absolute HLA-DQA1-DQB1 linked risk for developing type I diabetes before 40 years of age in the Belgian population: implications for future prevention studies.
    Van der Auwera BJ, Schuit FC, Weets I, Ivens A, Van Autreve JE, Gorus FK, Belgian Diabetes Registry.
    Hum Immunol; 2002 Jan 11; 63(1):40-50. PubMed ID: 11916169
    [Abstract] [Full Text] [Related]

  • 15. Association between autoantibody markers and subtypes of DR4 and DR4-DQ in Swedish children with insulin-dependent diabetes reveals closer association of tyrosine pyrophosphatase autoimmunity with DR4 than DQ8.
    Sanjeevi CB, Hagopian WA, Landin-Olsson M, Kockum I, Woo W, Palmer JP, Lernmark A, Dahlquist G.
    Tissue Antigens; 1998 Mar 11; 51(3):281-6. PubMed ID: 9550329
    [Abstract] [Full Text] [Related]

  • 16. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S, Sakamaki T, Konda S, Murata A, Wataki K, Kobayashi Y, Minamitani K, Miyamoto S, Sasaki N, Niimi H.
    Diabetes; 1997 Nov 11; 46(11):1893-7. PubMed ID: 9356042
    [Abstract] [Full Text] [Related]

  • 17. HLA DQA1-DQB1-TAP2 haplotypes in IDDM families: no evidence for an additional contribution to disease risk by the TAP2 locus.
    Esposito L, Lampasona V, Bosi E, Poli F, Ferrari M, Bonifacio E.
    Diabetologia; 1995 Aug 11; 38(8):968-74. PubMed ID: 7589884
    [Abstract] [Full Text] [Related]

  • 18. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
    El-Amir MI, El-Feky MA, Laine AP, Härkönen T, El-Badawy O, Eltayeb AA, El-Melegy TT, Kiviniemi M, Knip M, Ilonen J.
    Diabetes Metab Res Rev; 2015 Mar 11; 31(3):287-94. PubMed ID: 25256132
    [Abstract] [Full Text] [Related]

  • 19. Epidemiology, clinical aspects, and biology of IDDM patients under age 40 years. Comparison of data from Antwerp with complete ascertainment with data from Belgium with 40% ascertainment. The Belgian Diabetes Registry.
    Vandewalle CL, Coeckelberghs MI, De Leeuw IH, Du Caju MV, Schuit FC, Pipeleers DG, Gorus FK.
    Diabetes Care; 1997 Oct 11; 20(10):1556-61. PubMed ID: 9314635
    [Abstract] [Full Text] [Related]

  • 20. Specific human leukocyte antigen DQ influence on expression of antiislet autoantibodies and progression to type 1 diabetes.
    Redondo MJ, Babu S, Zeidler A, Orban T, Yu L, Greenbaum C, Palmer JP, Cuthbertson D, Eisenbarth GS, Krischer JP, Schatz D, Diabetes Prevention Trial Type 1 Study Group.
    J Clin Endocrinol Metab; 2006 May 11; 91(5):1705-13. PubMed ID: 16464953
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.